Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Dr Agarwal's Eye Hospital Ltd
BSE:526783

Watchlist Manager
Dr Agarwal's Eye Hospital Ltd Logo
Dr Agarwal's Eye Hospital Ltd
BSE:526783
Watchlist
Price: 5 318.3999 INR 0.75% Market Closed
Market Cap: ₹25.7B
Write Note Create Alert Ask AI

Wall St Price Targets

DRAGARWQ Price Targets Summary
Dr Agarwal's Eye Hospital Ltd

Wall Street analysts forecast DRAGARWQ stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DRAGARWQ is 612 INR with a low forecast of 606 INR and a high forecast of 630 INR.

DRAGARWQ Lowest Forecast
Wall Street Target
₹606
-89% Downside
DRAGARWQ Average Forecast
Wall Street Target
₹612
-88% Downside
DRAGARWQ Highest Forecast
Wall Street Target
₹630
-88% Downside
Lowest Forecast
Price Target
606 INR
89% Downside
Average Forecast
Price Target
612 INR
88% Downside
Highest Forecast
Price Target
630 INR
88% Downside
Dr Agarwal's Eye Hospital Ltd Competitors:
Price Targets

Revenue
Forecast

12% / Year
Past Growth
100% / Year
Estimated Growth
Estimates Accuracy
-77%
Average Miss
12% / Year
Past Growth
100% / Year
Estimated Growth
Estimates Accuracy
-77%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 100%.

What are analyst estimates?

Gross Profit
Forecast

15% / Year
Past Growth
266% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
15% / Year
Past Growth
266% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 1 year is 266%.

What are analyst estimates?

Operating Income
Forecast

23% / Year
Past Growth
120% / Year
Estimated Growth
Estimates Accuracy
-65%
Average Miss
23% / Year
Past Growth
120% / Year
Estimated Growth
Estimates Accuracy
-65%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 2 years is 120%.

What are analyst estimates?

Pre-Tax Income
Forecast

26% / Year
Past Growth
80% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
26% / Year
Past Growth
80% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 1 year is 80%.

What are analyst estimates?

Net Income
Forecast

27% / Year
Past Growth
74% / Year
Estimated Growth
Estimates Accuracy
-38%
Average Miss
27% / Year
Past Growth
74% / Year
Estimated Growth
Estimates Accuracy
-38%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 3 years is 74%.

What are analyst estimates?

Continue DRAGARWQ Research

Summary
DRAGARWQ intrinsic value, competitors valuation, and company profile.
DCF Valuation
DRAGARWQ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DRAGARWQ stock valuation using valuation multiples.
Wall St Estimates
DRAGARWQ price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DRAGARWQ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DRAGARWQ's stock price target?
Price Target
612 INR

According to Wall Street analysts, the average 1-year price target for DRAGARWQ is 612 INR with a low forecast of 606 INR and a high forecast of 630 INR.

What is the Revenue forecast for Dr Agarwal's Eye Hospital Ltd?
Projected CAGR
100%

Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 100%.

What is the Gross Profit forecast for Dr Agarwal's Eye Hospital Ltd?
Projected CAGR
266%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 1 year is 266%.

What is the Operating Income forecast for Dr Agarwal's Eye Hospital Ltd?
Projected CAGR
120%

Over the last 13 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 2 years is 120%.

What is the Pre-Tax Income forecast for Dr Agarwal's Eye Hospital Ltd?
Projected CAGR
80%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 1 year is 80%.

What is the Net Income forecast for Dr Agarwal's Eye Hospital Ltd?
Projected CAGR
74%

Over the last 13 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 3 years is 74%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.